Willingdon Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Willingdon Wealth Management’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$218K	Sell	6,885 -70	-1%	-$2.68K	0.05%	111
2019 Q4	$294K	Buy	6,955 +1,084	+18%	+$40.2K	0.06%	114
2019 Q3	$185K	Buy	5,871 +441	+8%	+$15.5K	0.04%	127
2019 Q2	$196K	Buy	5,430 +247	+5%	+$8.52K	0.05%	124
2019 Q1	$188K	Buy	5,183 +473	+10%	+$15.8K	0.05%	129
2018 Q4	$133K	Sell	4,710 -490	-9%	-$16.2K	0.04%	143
2018 Q3	$205K	Buy	5,200 +2,371	+84%	+$89.9K	0.06%	124
2018 Q2	$105K	Buy	2,829 +1,741	+160%	+$63.2K	0.03%	142
2018 Q1	$37K	Buy	+1,088	New	+$38.1K	0.01%	181

Other funds holding SBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

Willingdon Wealth Management's SBIO Position: Q1 2020 in Review

Willingdon Wealth Management reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 1% in Q1 2020, selling an estimated $2.68K and leaving 6,885 shares worth $218K. The position accounts for 0.05% of the portfolio, ranked #111.

Willingdon Wealth Management first reported a position in SBIO in Q1 2018 and has held it in 9 quarters since. The position peaked at $294K in Q4 2019. 47 funds tracked by Wall St. Rank hold SBIO as of Q1 2020.

Willingdon Wealth Management held 6,885 shares of ALPS Medical Breakthroughs ETF worth $218K as of Q1 2020.
Willingdon Wealth Management sold 70 ALPS Medical Breakthroughs ETF shares in Q1 2020, an estimated $2.68K.
ALPS Medical Breakthroughs ETF made up 0.05% of Willingdon Wealth Management's portfolio in Q1 2020, its #111 holding.
Willingdon Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q1 2018 and has held it in 9 quarters since.
Willingdon Wealth Management's ALPS Medical Breakthroughs ETF position peaked at $294K in Q4 2019.
47 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.